& Canterini, S
[DOI] [PubMed] [Google Scholar] Odii B.O., Coussons P
*Correspondence: Fang Deng, [email protected] This article was submitted to Inflammation, a section of the journal Frontiers in Immunology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
The primary components include tumor cells, cancer-associated fibroblasts (CAFs), immune cells such as macrophages, T cells, and B cells, vascular endothelial cells, and extracellular matrix (ECM) components
Our compounded IV B12 therapies are prepared pursuant to provider-directed prescriptions for patients experiencing fatigue, low energy, or deficiency-related symptoms